Alexion Pharma Belgium SRL

9.3 FTE

Alexion Pharma Belgium reported revenue of €20.8m for the 2025 financial year (annual accounts filed with the NBB on 04 Nov 2026), with 9.3 full-time equivalents.

By total assets for 2025, Alexion Pharma Belgium ranks in the top half of the 173 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0895.692.555 · VAT BE0895692555
1000 Brussels
active in Manufacture of medicaments (NACE 21201)
operating since 13 Feb 2008 (≈ 18 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Alexion Pharma Belgium shows with a free account.

See the score
Profile
SRL Micro · 9.3 FTE since 2008
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Revenue€20.8m
Net result455,566 €
Equity€3.44m
Cash22 €
EBITDA661,391 €
Total assets€8.68m
Headcount (avg FTE)9.3
The line marks its sector median: 41.4% (21 companies).

Change 2022 → 2025: Revenue +49 % Equity +49 % Total assets +1 % Headcount (avg FTE) +60 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Alexion Pharma Belgium's annual accounts

20252024202320222021
Revenue€20.8m
Net result455,566 €
Equity€3.44m
Cash22 €
EBITDA661,391 €
Total assets€8.68m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 04 Nov 2026
  • Year ended 31 Dec 2024filed on 30 Jul 2025
  • Year ended 31 Dec 2023filed on 30 Jul 2024
  • Year ended 31 Dec 2022filed on 07 Jul 2023
  • Year ended 31 Dec 2021filed on 13 Jul 2022

Alexion Pharma Belgium's financial analysis

Management and control of Alexion Pharma Belgium

3 active director(s) in the register.

Alexion Pharma Belgium's shareholders and holdings →

Alexion Pharma Belgium's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0895.692.555
VAT number
BE0895692555
Peppol
Registered · 0208:0895692555 · as of 10 Nov 2026
Legal form
SRL
Incorporated
13 Feb 2008
Registered office
1000 Brussels
Size
Micro · 9.3 FTE
Latest accounts
2025 · filed on 04 Nov 2026
Activity
Manufacture of medicaments (NACE 21201)

Alexion Pharma Belgium (SRL) has been based in Brussels since 2008, active in: manufacture of medicaments. For 2025, it reports revenue of €20.8m, a net profit of 455,566 € and equity of €3.44m. With 9.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 39.7%, below the median of its sector (41.4%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Alexion Pharma Belgium

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Alexion Pharma Belgium

What is the revenue of Alexion Pharma Belgium?

According to the 2025 annual accounts filed with the NBB, the revenue of Alexion Pharma Belgium amounts to 20,845,123 €.

What is the VAT number of Alexion Pharma Belgium?

In Belgium, the VAT number is the company number prefixed with BE: BE0895692555 for Alexion Pharma Belgium, if the company is VAT-registered. Its company number (CBE) is 0895.692.555.

Where is the registered office of Alexion Pharma Belgium?

According to the CBE register, the registered office of Alexion Pharma Belgium is in 1000 Brussels.

What is the equity of Alexion Pharma Belgium?

At the close of the 2025 financial year, the equity of Alexion Pharma Belgium amounts to 3,442,924 €, a solvency of 39.7% of total assets.

How many people work at Alexion Pharma Belgium?

9.3 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Alexion Pharma Belgium?

The register lists 3 active mandates at Alexion Pharma Belgium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Alexion Pharma Belgium within its sector?

By total assets for 2025, Alexion Pharma Belgium ranks in the top half of the 173 companies in its sector (NACE 2120) in Belgium that filed accounts for that financial year.

Idonis

The full file of Alexion Pharma Belgium

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 07 Nov 2026

No credit card, no commitment.

What each plan unlocks →